Obesity, type 2 diabetes mellitus and cardiovascular disease risk: An uptodate in the management of polycystic ovary syndrome

Francesco Orio, Giovanna Muscogiuri, Cinar Nese, Stefano Palomba, Silvia Savastano, Domenico Tafuri, Giorgio Colarieti, Giovanbattista La Sala, Annamaria Colao, Bulent O. Yildiz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women and is characterized by two of the following three features: oligoovulation or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries. Summary: It has been demonstrated that PCOS includes a complex number of systemic symptoms in addition to symptoms related to the reproductive apparatus. It has been associated with obesity, metabolic syndrome, type 2 diabetes and an increased risk of cardiovascular disease. Several clinical and basic studies have investigated the link between PCOS and the cardiovascular disease risk, which seems to be due to blunted lipid/glucose metabolism, hypertension, and systemic inflammatory and coagulation disorders. Therefore, the current manuscript aims to review the main findings on PCOS and obesity/. obesity-related disease (glucose derangements and cardiovascular disease risk factors). Key message: Although there are no long-term data on the morbidity and mortality for cardiovascular disease in PCOS, it is advisable to perform a careful metabolic and cardiovascular assessment in women with PCOS in order to tailor the most suitable strategy to prevent cardiovascular disease.

Original languageEnglish
JournalEuropean Journal of Obstetrics, Gynecology and Reproductive Biology
DOIs
Publication statusAccepted/In press - Jun 22 2016

Fingerprint

Polycystic Ovary Syndrome
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Obesity
Anovulation
Hyperandrogenism
Glucose
Manuscripts
Lipid Metabolism
Ovary
Hypertension
Morbidity
Mortality

Keywords

  • Cardiovascular disease
  • Environment
  • Lifestyle
  • Obesity
  • PCOS
  • Type 2 diabetes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Obesity, type 2 diabetes mellitus and cardiovascular disease risk : An uptodate in the management of polycystic ovary syndrome. / Orio, Francesco; Muscogiuri, Giovanna; Nese, Cinar; Palomba, Stefano; Savastano, Silvia; Tafuri, Domenico; Colarieti, Giorgio; La Sala, Giovanbattista; Colao, Annamaria; Yildiz, Bulent O.

In: European Journal of Obstetrics, Gynecology and Reproductive Biology, 22.06.2016.

Research output: Contribution to journalArticle

Orio, Francesco ; Muscogiuri, Giovanna ; Nese, Cinar ; Palomba, Stefano ; Savastano, Silvia ; Tafuri, Domenico ; Colarieti, Giorgio ; La Sala, Giovanbattista ; Colao, Annamaria ; Yildiz, Bulent O. / Obesity, type 2 diabetes mellitus and cardiovascular disease risk : An uptodate in the management of polycystic ovary syndrome. In: European Journal of Obstetrics, Gynecology and Reproductive Biology. 2016.
@article{38ead5c371c14f62acba0af3e9296356,
title = "Obesity, type 2 diabetes mellitus and cardiovascular disease risk: An uptodate in the management of polycystic ovary syndrome",
abstract = "Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women and is characterized by two of the following three features: oligoovulation or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries. Summary: It has been demonstrated that PCOS includes a complex number of systemic symptoms in addition to symptoms related to the reproductive apparatus. It has been associated with obesity, metabolic syndrome, type 2 diabetes and an increased risk of cardiovascular disease. Several clinical and basic studies have investigated the link between PCOS and the cardiovascular disease risk, which seems to be due to blunted lipid/glucose metabolism, hypertension, and systemic inflammatory and coagulation disorders. Therefore, the current manuscript aims to review the main findings on PCOS and obesity/. obesity-related disease (glucose derangements and cardiovascular disease risk factors). Key message: Although there are no long-term data on the morbidity and mortality for cardiovascular disease in PCOS, it is advisable to perform a careful metabolic and cardiovascular assessment in women with PCOS in order to tailor the most suitable strategy to prevent cardiovascular disease.",
keywords = "Cardiovascular disease, Environment, Lifestyle, Obesity, PCOS, Type 2 diabetes",
author = "Francesco Orio and Giovanna Muscogiuri and Cinar Nese and Stefano Palomba and Silvia Savastano and Domenico Tafuri and Giorgio Colarieti and {La Sala}, Giovanbattista and Annamaria Colao and Yildiz, {Bulent O.}",
year = "2016",
month = "6",
day = "22",
doi = "10.1016/j.ejogrb.2016.08.026",
language = "English",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Obesity, type 2 diabetes mellitus and cardiovascular disease risk

T2 - An uptodate in the management of polycystic ovary syndrome

AU - Orio, Francesco

AU - Muscogiuri, Giovanna

AU - Nese, Cinar

AU - Palomba, Stefano

AU - Savastano, Silvia

AU - Tafuri, Domenico

AU - Colarieti, Giorgio

AU - La Sala, Giovanbattista

AU - Colao, Annamaria

AU - Yildiz, Bulent O.

PY - 2016/6/22

Y1 - 2016/6/22

N2 - Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women and is characterized by two of the following three features: oligoovulation or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries. Summary: It has been demonstrated that PCOS includes a complex number of systemic symptoms in addition to symptoms related to the reproductive apparatus. It has been associated with obesity, metabolic syndrome, type 2 diabetes and an increased risk of cardiovascular disease. Several clinical and basic studies have investigated the link between PCOS and the cardiovascular disease risk, which seems to be due to blunted lipid/glucose metabolism, hypertension, and systemic inflammatory and coagulation disorders. Therefore, the current manuscript aims to review the main findings on PCOS and obesity/. obesity-related disease (glucose derangements and cardiovascular disease risk factors). Key message: Although there are no long-term data on the morbidity and mortality for cardiovascular disease in PCOS, it is advisable to perform a careful metabolic and cardiovascular assessment in women with PCOS in order to tailor the most suitable strategy to prevent cardiovascular disease.

AB - Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women and is characterized by two of the following three features: oligoovulation or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries. Summary: It has been demonstrated that PCOS includes a complex number of systemic symptoms in addition to symptoms related to the reproductive apparatus. It has been associated with obesity, metabolic syndrome, type 2 diabetes and an increased risk of cardiovascular disease. Several clinical and basic studies have investigated the link between PCOS and the cardiovascular disease risk, which seems to be due to blunted lipid/glucose metabolism, hypertension, and systemic inflammatory and coagulation disorders. Therefore, the current manuscript aims to review the main findings on PCOS and obesity/. obesity-related disease (glucose derangements and cardiovascular disease risk factors). Key message: Although there are no long-term data on the morbidity and mortality for cardiovascular disease in PCOS, it is advisable to perform a careful metabolic and cardiovascular assessment in women with PCOS in order to tailor the most suitable strategy to prevent cardiovascular disease.

KW - Cardiovascular disease

KW - Environment

KW - Lifestyle

KW - Obesity

KW - PCOS

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84994115576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994115576&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2016.08.026

DO - 10.1016/j.ejogrb.2016.08.026

M3 - Article

AN - SCOPUS:84994115576

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

ER -